Cleveland Clinic researchers have used nanoparticles to develop a potential vaccine candidate against Dabie Bandavirus, formerly known as Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a tick-borne virus that currently has no prevention, treatment or cure.
Medicare’s first drug negotiation list likely to fuel public pricing discussions for pharma marketers
Who’s on the list? That’s the question many in the pharma industry are asking today about CMS releasing the names of the first 10 drugs,
August 30, 2023